ÎÚÑ»´«Ã½

Jump to Main Content

Newsroom

Submit
Reset

ASH Names New Blood Editor in Chief

Oct 31
2024

Five-year term of Dr. Andrew Roberts to begin in January 2025 (WASHINGTON, Oct. 31, 2024) — The ÎÚÑ»´«Ã½ (ASH) has selected Andrew Roberts, MBBS, PhD, clinical hematologist at the Royal Melbourne Hospital and Peter MacCallum Ca...

Read more

New Leadership Elected to the ÎÚÑ»´«Ã½

Oct 28
2024

(WASHINGTON, October 28, 2024) – The ÎÚÑ»´«Ã½ (ASH), the world’s largest professional society focused on advancing the field of blood disorders, announced the election of four new members to its Executive Committee f...

Read more

ASH Announces Editors in Chief of Two New Blood Journals

Oct 09
2024

Drs. Willem Fibbe and Patrick Gallagher selected to head new specialty hematology publications (WASHINGTON, Oct. 9, 2024) — The ÎÚÑ»´«Ã½ (ASH) has selected Willem Fibbe, MD, and Patrick Gallagher, MD, to serve as the inau...

Read more

Food Deserts, Limited Access to Transportation Linked to More Complications Among Preschool Children with SCD

Oct 07
2024

Social factors significantly affected patient health despite wrap-around care (WASHINGTON – October 7, 2024) - A new study finds that preschool-aged children with sickle cell disease (SCD) who live in food deserts and have limited access to transpo...

Read more

Cilta-cel Found Highly Effective in First Real-World Study

Oct 04
2024

Study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma (WASHINGTON – October 4, 2024) In the first study to report real-world outco...

Read more

CAR-T Safe and Effective on an Outpatient Basis

Sep 30
2024

Study of liso-cel in patients with relapsed or refractory large B-cell lymphoma points to the benefits of bringing advanced therapies closer to patients, minimizing hospitalizations (WASHINGTON – September 30, 2024) In the largest prospective study...

Read more

ASH Announces Sickle Cell Disease Research Priorities to Accelerate Treatments and Comprehensive Care

Sep 25
2024

Research priorities will help direct the field and deliver progress for the next five years (WASHINGTON, September 25, 2024) — The ÎÚÑ»´«Ã½ (ASH) has released new comprehensive sickle cell disease (SCD) research prioritie...

Read more

Stroke Rates Increasing in Individuals Living with SCD Despite Treatment Guidelines

Sep 20
2024

Rising stroke rates indicate need for greater adherence to standard of care and attention to modifiable risk factors (WASHINGTON, September 20, 2024) –The incidence of stroke continues to increase for adults and children living with sickle cell...

Read more

Study Finds Unique Pattern of Blood Clots in Sickle Cell Trait but Low Overall Clot Risk

Sep 12
2024

23andMe research cohort analysis finds higher risk of venous thromboembolism and pulmonary embolism for people with sickle cell trait, yet relatively low risk of blood clotting overall (WASHINGTON – September 12, 2024) The risk of venous thro...

Read more

ASH Recognizes 2024 Quality Improvement Champions

Aug 27
2024

ASH Quality Improvement Champions are standardizing treatment, implementing clinical guidelines to improve patient safety (WASHINGTON, August 27, 2024) – The ÎÚÑ»´«Ã½ (ASH) recognizes Josie Fernandez Sanchez, MD, of Texas Chil...

Read more